Solesta Side Effects
Generic name: dextranomer / sodium hyaluronate
Medically reviewed by Drugs.com. Last updated on Jun 11, 2022.
Note: This document contains side effect information about dextranomer / sodium hyaluronate. Some dosage forms listed on this page may not apply to the brand name Solesta.
Applies to dextranomer / sodium hyaluronate: injectable gel.
You should not receive this medicine if you have: rectal infection or bleeding, rectal fissure, rectal tumor, rectal malformation, rectal prolapse, an abnormal passageway between the rectum and vagina, stenosis (narrowing) of your anal canal, a rectal or anal implant (other than Solesta), congested blood vessels in the anus or rectum, inflammatory bowel disease, a history of radiation to your pelvic area, or a weak immune system.
Get emergency medical help if you have any of these signs of an allergic reaction while taking dextranomer / sodium hyaluronate: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
-
fever;
-
sudden or constant urge to pass bowel movements, or feeling like you cannot completely empty your bowels;
-
heavy rectal bleeding;
-
diarrhea that is bloody;
-
painful or difficult urination;
-
severe rectal itching, swelling, pain, or drainage (pus);
-
bulging tissue from your rectum; or
-
sharp pain or stinging sensation during a bowel movement.
Common side effects may include:
-
constipation, diarrhea;
-
pain where the medicine was injected;
-
mild rectal bleeding;
-
mild rectal itching or discomfort;
-
dizziness, chills, cold sweat;
-
stomach pain; or
-
pain during sexual intercourse.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
More about Solesta (dextranomer / sodium hyaluronate)
Patient resources
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
